HCPCS Level II code C1780 designates a new-technology intraocular lens intended for implantation following cataract extraction or refractive lens procedures. As a specific HCPCS Level II device code, it identifies implants that differ from standard intraocular lenses based on novel design, materials, or clinical features. Nationally, such codes matter for device identification, coverage determination, and claims processing because payers may apply distinct coverage rules or prior authorization requirements for new-technology implants.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how C1780 is used on claims, payer coverage patterns, and the clinical context for intraocular lens implantation. Readers will find benchmarks for utilization where available, summaries of common payer policies and prior authorization considerations, and clinical context on when new-technology intraocular lenses are typically implanted (e.g., cataract surgery and refractive lens exchange).

This resource is intended to clarify the code purpose, common sites of service, and the areas stakeholders should review when billing and seeking coverage for newly categorized intraocular lenses. Data not available in the input will be explicitly noted in relevant sections.